Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Eiger BioPharmaceuticals, Inc.
3199
Eiger BioPharmaceuticals, Inc.
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Eiger is a biopharmaceutical company developing new antiviral agents againstnovel targets in the treatment of hepatitis.
Suggest edits
Founded
2008
Raised
$28M
Follow us
Companies in the same industry
Prospective Research
Esperance Pharmaceuticals
Clarity Pharmaceuticals
Stellar Biotechnologies
CANbridge Life Sciences Ltd.
Antengene Corporation
Camallergy
SIRE®
Harbour BioMed
Everest Medicines
Alexa global traffic share
Overview
Funding
2
Add info
Add round
04 Jan
2017
$25,000,000
Post-IPO debt
Oxford Finance
Eiger Biopharma Completes 25 Million Debt Financing With Oxford Finance
biospace
29 Apr
2016
$3,000,000
Venture capital
SEC FORM D
sec
